A detailed history of Navalign, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Navalign, LLC holds 12,922 shares of MRK stock, worth $1.47 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
12,922
Previous 12,574 2.77%
Holding current value
$1.47 Million
Previous $1.66 Million 3.62%
% of portfolio
0.51%
Previous 0.55%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$123.8 - $132.96 $43,082 - $46,270
348 Added 2.77%
12,922 $1.6 Million
Q1 2024

Apr 12, 2024

SELL
$113.24 - $131.95 $30,801 - $35,890
-272 Reduced 2.12%
12,574 $1.66 Million
Q4 2023

Jan 18, 2024

SELL
$100.18 - $109.02 $23,642 - $25,728
-236 Reduced 1.8%
12,846 $1.4 Million
Q3 2023

Oct 10, 2023

BUY
$102.95 - $114.33 $51,989 - $57,736
505 Added 4.02%
13,082 $1.35 Million
Q2 2023

Jul 14, 2023

SELL
$108.61 - $118.38 $22,156 - $24,149
-204 Reduced 1.6%
12,577 $1.45 Million
Q1 2023

Apr 19, 2023

SELL
$102.94 - $114.86 $84,204 - $93,955
-818 Reduced 6.02%
12,781 $1.36 Million
Q4 2022

Feb 06, 2023

SELL
$87.44 - $112.11 $47,917 - $61,436
-548 Reduced 3.87%
13,599 $1.51 Million
Q3 2022

Nov 02, 2022

SELL
$84.53 - $94.96 $9,213 - $10,350
-109 Reduced 0.76%
14,147 $1.22 Million
Q2 2022

Jul 27, 2022

SELL
$83.49 - $94.64 $30,306 - $34,354
-363 Reduced 2.48%
14,256 $1.3 Million
Q1 2022

Apr 29, 2022

BUY
$73.51 - $82.4 $22,420 - $25,132
305 Added 2.13%
14,619 $1.23 Million
Q4 2021

Feb 08, 2022

SELL
$72.28 - $90.54 $6,216 - $7,786
-86 Reduced 0.6%
14,314 $1.1 Million
Q3 2021

Nov 03, 2021

BUY
$71.68 - $78.83 $92,252 - $101,454
1,287 Added 9.81%
14,400 $1.08 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $28,756 - $31,807
409 Added 3.22%
13,113 $1.02 Million
Q1 2021

May 10, 2021

BUY
$68.86 - $81.11 $874,797 - $1.03 Million
12,704 New
12,704 $979,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Navalign, LLC Portfolio

Follow Navalign, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navalign, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Navalign, LLC with notifications on news.